Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3137750
Max Phase: Preclinical
Molecular Formula: C30H46N2O5S
Molecular Weight: 546.77
Molecule Type: Small molecule
Associated Items:
ID: ALA3137750
Max Phase: Preclinical
Molecular Formula: C30H46N2O5S
Molecular Weight: 546.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](CCC(=O)Nc1cccc(S(N)(=O)=O)c1)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C30H46N2O5S/c1-18(7-10-27(35)32-20-5-4-6-22(17-20)38(31,36)37)23-8-9-24-28-25(12-14-30(23,24)3)29(2)13-11-21(33)15-19(29)16-26(28)34/h4-6,17-19,21,23-26,28,33-34H,7-16H2,1-3H3,(H,32,35)(H2,31,36,37)/t18-,19+,21-,23-,24+,25+,26-,28+,29+,30-/m1/s1
Standard InChI Key: QHBHZWRZXZZJCT-WVPCZKKUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 546.77 | Molecular Weight (Monoisotopic): 546.3127 | AlogP: 4.68 | #Rotatable Bonds: 6 |
Polar Surface Area: 129.72 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.08 | CX Basic pKa: | CX LogP: 3.75 | CX LogD: 3.75 |
Aromatic Rings: 1 | Heavy Atoms: 38 | QED Weighted: 0.41 | Np Likeness Score: 0.84 |
1. Scozzafava A, Supuran CT.. (2002) Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails., 12 (12): [PMID:12039560] [10.1016/s0960-894x(02)00252-4] |
Source(1):